ArticleHuman gene therapy2015

Intratumoral injection of Ad-ISF35 (Chimeric CD154) breaks tolerance and induces lymphoma tumor regression.

Mauricio Urquiza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.